NanoViricides Inc. (NNVC)

[BonelessCat]

In the world arena of viral infections and epidemics, why the emphasis on FDA approval. The market in Europe is as big as the US as is East Asia.

Then there is the Breakthrough Therapy designation where a single, combined Phase 2/3a can lead to emergency use authorization or even approval. This stuff isn't a vaccine where dangers only show in expanded trials. Nanoviricides either prove to be as nontoxic in humans as in mice or they induce some strange human immune response, or it will have some Bizzarro liver/kidney interaction not seen in other species. We will know that after Phase 1 dose escalation. After that, it will either work in 6 to 24 hours, or it won't.